在葡萄糖皮质类药物治疗期间,支持和抗凝剂之间的静血平衡得到维持
Atsuki Yamashita1, Chiai Nagae2, Yotaro Umezawa1
1Department of Pediatrics, St. Marianna University Yokohama Seibu Hospital, Yokohama, Japan.
Pediatric blood & cancer
|December 11, 2023
概括
葡萄糖皮质类药物治疗增强了凝血因子和抗凝血剂,保持了血静平衡. 这项研究澄清了在非炎症条件下葡萄糖皮质醇对血液凝固的影响.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 血栓形成研究研究
背景情况:
- 葡萄糖皮质类药物与增加静脉血栓形成风险有关.
- 葡萄糖皮质激素治疗会影响凝血和抗凝血剂水平,但其对血液静止的净影响尚不清楚.
- 这项研究研究了葡萄糖皮质体对非炎症性疾病的凝血效应.
研究的目的:
- 为了检查葡萄糖皮质醇治疗后的综合凝固概况.
- 为了确定葡萄糖皮质体对血静功能的直接贡献.
- 评估使用和不使用可溶性血栓模块素 (sTM) 的血栓生成潜力的变化.
主要方法:
- 对接受葡萄糖皮质类药物治疗的原发性免疫性血栓塞缩症患者的潜在招募.
- 凝血因子和抗凝血剂的测量.
- 评估血栓生成潜力 (ETP,峰值) 有或没有sTM.
主要成果:
- 葡萄糖皮质体治疗缩短了激活的部分血栓形成时间,并增加了XVIII,IX,XI和XII因子.
- 治疗后抗血素和蛋白C (PC) 的活性增加.
- 在没有sTM的情况下,血栓生成 (ETP,峰值) 增加,但ETP-TM和峰值-TM比率下降,表明增强PC通路抗凝功能.
结论:
- 葡萄糖皮质类药物可以提高促凝血剂 (因子) 和抗凝血剂 (抗血,PC) 的水平.
- 尽管凝血因子活性增加,但血静平衡似乎保持不变.
- 这项研究阐明了葡萄糖皮质类药物对血液静止的复杂影响.
相关概念视频
Homeostatic Imbalance
23.1K
Homeostasis is the maintenance of a stable internal environment within the body, which is crucial for the proper functioning of cells, tissues, organs, and organ systems. The body has various control mechanisms that work together to regulate various physiological parameters such as temperature, blood pressure, pH balance, and fluid balance, to name a few. These control mechanisms are based on feedback loops that can be either positive or negative.
However, sometimes these feedback loops fail,...
However, sometimes these feedback loops fail,...
23.1K
Hypoglycemia and Glucagon
266
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
266
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
121
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
121
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708
Disorders of Hemostasis
922
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
922


